ABBVIE INC (ABBV) Stock Analyst Ratings
USA - NYSE:ABBV - US00287Y1091 - Common Stock
232.36 USD
+0.07 (+0.03%)
233.21 USD
+0.85 (+0.37%)
ChartMill assigns a Buy % Consensus number of 79% to ABBV. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 242.66. This target is 4.43% above the current price.
ABBV was analyzed by 37 analysts. The buy percentage consensus is at 79. So analysts seem to be have mildly positive about ABBV.
In the previous month the buy percentage consensus was at a similar level.
ABBV was analyzed by 37 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-11-07 | UBS | Maintains | Neutral -> Neutral |
| 2025-11-05 | Piper Sandler | Reiterate | Overweight -> Overweight |
| 2025-11-03 | JP Morgan | Maintains | Overweight -> Overweight |
| 2025-11-03 | Citigroup | Maintains | Neutral -> Neutral |
| 2025-10-20 | Guggenheim | Maintains | Buy -> Buy |
| 2025-10-17 | Raymond James | Reiterate | Outperform -> Outperform |
| 2025-10-10 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2025-10-03 | B of A Securities | Maintains | Neutral -> Neutral |
| 2025-10-01 | HSBC | Downgrade | Buy -> Hold |
| 2025-09-22 | Evercore ISI Group | Maintains | Outperform -> Outperform |
| 2025-09-17 | Berenberg | Upgrade | Hold -> Buy |
| 2025-09-16 | JP Morgan | Maintains | Overweight -> Overweight |
| 2025-09-15 | Cantor Fitzgerald | Maintains | Overweight -> Overweight |
| 2025-09-12 | BMO Capital | Maintains | Outperform -> Outperform |
| 2025-09-12 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2025-08-01 | Guggenheim | Maintains | Buy -> Buy |
| 2025-08-01 | Raymond James | Maintains | Outperform -> Outperform |
| 2025-08-01 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2025-05-14 | Citigroup | Downgrade | Buy -> Neutral |
| 2025-04-29 | Guggenheim | Maintains | Buy -> Buy |
| 2025-04-28 | Evercore ISI Group | Maintains | Outperform -> Outperform |
| 2025-04-28 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2025-04-22 | Cantor Fitzgerald | Initiate | Overweight |
| 2025-04-17 | Guggenheim | Reiterate | Buy -> Buy |
| 2025-04-09 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2025-03-05 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2025-03-04 | B of A Securities | Maintains | Neutral -> Neutral |
| 2025-02-03 | Guggenheim | Maintains | Buy -> Buy |
| 2025-02-03 | BMO Capital | Maintains | Outperform -> Outperform |
| 2025-02-03 | UBS | Maintains | Neutral -> Neutral |
ABBVIE INC / ABBV FAQ
Can you provide the average price target for ABBVIE INC stock?
37 analysts have analysed ABBV and the average price target is 242.66 USD. This implies a price increase of 4.43% is expected in the next year compared to the current price of 232.36.
How do analysts rate ABBVIE INC (ABBV)?
The consensus rating for ABBVIE INC (ABBV) is 78.9189 / 100 . This indicates that analysts generally have a positive outlook on the stock.
How many analysts cover ABBVIE INC (ABBV) stock?
The number of analysts covering ABBVIE INC (ABBV) is 37.